<qa>  What is the name of the immunotherapy that is followed by a YttriumI. To determine the progression free survival in colorectal cancer patients after hepatic resection of liver metastases and FOLFOX or leucovorin calcium, fluorouracil, and irinotecan hydrochloride FOLFIRI chemotherapy - Bevacizumab, or capecitabine and oxaliplatin XELOX,followed by intravenous IV yttrium-90 90Y M5A anti-CEA antibody. 